News & Blog

Latest from the Blog

  1. June 25, 2013

    Jumpstarting Brain Tumor Drug Development

    National Brain Tumor Society staff and advisors recently met with the U.S. Food and Drug Administration (FDA) to discuss how various stakeholders in brain tumor drug development could work together to increase the volume and speed of approvals for new treatments for this disease.

    Read more | 
  2. June 17, 2013

    National Brain Tumor Society’s First Community Research Fund

    Blog_Oligo_GreeneFamily_565x274

    The National Brain Tumor Society and OligoNation announced Dr. David Louis, MD, of Massachusetts General Hospital and Harvard Medical School, and Dr. Anders Persson, PhD, of The University of California, San Francisco as the first grant recipients of the Oligodendroglioma Research Fund.

    Read more | 
  3. June 3, 2013

    A Response to the Results of Avastin Clinical Trials

    National Brain Tumor Society comments on the recently announced results of the AVAglio and RTOG clinical trials.

    Read more | 
Share